December 18, 2024 – Abbott introduced the profitable completion of the world's first in-human leadless left bundle department space pacing (LBBAP) procedures utilizing the corporate's experimental AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system, as a part of a feasibility research. These procedures mark the primary time a leadless pacemaker has been implanted within the left bundle department space, a key a part of the center's electrical conduction system, designed to imitate the center's pure beat and provides individuals with slower-than-normal coronary heart rhythms new potential provide. therapy choice.

The groundbreaking procedures had been a part of the potential Leadless CSP feasibility research, which is evaluating the acute security and efficiency of the experimental AVEIR CSP leadless pacemaker system. The seamless integration of CSP procedures with leadless pacemaker know-how has the potential to supply distinctive benefits over conventional pacemakers. Leadless pacing programs get rid of the necessity for cardiac leads and a pulse generator beneath the pores and skin and keep away from the long-term threat of lead and pocket-related problems. Consequently, leadless pacemakers such because the AVEIR product household are a possible answer to a few of the problems usually related to conventional pacemakers.

Proceed studying